Creat Group

DGAP-News: Biotest AG: Biotest announces the new Renate & Hans Schleussner Award for scientific research

Retrieved on: 
Wednesday, September 15, 2021
Pathology, Creat Group, Infection, Immune system, Antibody, Disease, Renatus, Supervisory board, University, Hospital, Research, Degenerative disease, Vaccine

In memory of the Schleussner family who founded Biotest, the new research award will be named the Renate & Hans Schleussner Award

Key Points: 
  • In memory of the Schleussner family who founded Biotest, the new research award will be named the Renate & Hans Schleussner Award
    Dreieich, 15 September 2021.
  • Biotest announced today that a new scientific award, the Renate & Hans Schleussner Award, which will be available and open for application from now on.
  • The daughter from Renate & Hans, Cathrin Schleussner was a member of the Supervisory Board of "Biotest AG" since 2001 and held the position of Deputy Chairman from 2004 until the takeover by the Chinese "Creat Group" in 2018.
  • The ordinary and preference shares of Biotest AG are listed in the Prime Standard on the German stock exchange.

DGAP-News: Biotest AG:

Retrieved on: 
Sunday, October 4, 2020
Creat Group

Bloomberg reported on 2 October 2020 that, according to informed circles, a private equity firm had approached the Chinese Creat Group Corp. to acquire a stake in Biotest AG.

Key Points: 
  • Bloomberg reported on 2 October 2020 that, according to informed circles, a private equity firm had approached the Chinese Creat Group Corp. to acquire a stake in Biotest AG.
  • The decision process regarding the future of the majority stake in Biotest AG is completely open, so that rumours of a sale are pure speculation.
  • Biotest AG will continue to inform the capital market and the public in accordance with the legal requirements.
  • The ordinary and preference shares of Biotest AG are listed in the Prime Standard on the German stock exchange.